Senior insider sale
KYVERNA THERAPEUTICS, INC. — senior position signals high conviction
$140.4K
16.63K shares
What this filing means
SPIEGELMAN DANIEL K plans to sell 16.63K shares of KYVERNA THERAPEUTICS, INC. valued at approximately $140.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001950047-26-003105
Director
Since Feb 2024
16.63K
Shares to sell
$140.4K
Approx. market value
16.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
2/24/2026
16.63KTotal acquired16.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Not Applicable | 16.63K | — |
| Total | 16.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.63K
Market value
$140.4K
3/31/2026
Total
Units
16.63K
Value
$140.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/31/2026 | 16.63K | $140.4K | NASDAQ | Planned |
| Total | 16.63K | $140.4K | ||